![Timothy Sullivan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Timothy Sullivan
Directeur Financier/CFO chez
APELLIS PHARMACEUTICALS, INC.
Profil
Timothy Eugene Sullivan est directeur financier et trésorier chez Apellis Pharmaceuticals, Inc. Dans le passé, M. Sullivan a occupé les postes de vice-président exécutif et responsable du développement de l'entreprise chez Rafael Pharmaceuticals, Inc, de directeur général et responsable des services bancaires d'investissement dans le domaine des sciences de la vie chez Citizens Bank, NA (Providence, Rhode Island) et d'associé chez Aju IB Investment Co, Ltd. (capital-investissement). M. Sullivan a obtenu un MBA à la Columbia Business School et un diplôme de premier cycle à l'Université de Harvard.
Postes actifs de Timothy Sullivan
| Sociétés | Poste | Début |
|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Directeur Financier/CFO | 01/10/2017 |
Anciens postes connus de Timothy Sullivan
| Sociétés | Poste | Fin |
|---|---|---|
Aju IB Investment Co., Ltd. (Private Equity)
 Aju IB Investment Co., Ltd. (Private Equity) Investment ManagersFinance Aju IB is a long-term investor focused on high technology Korean companies with significant growth potential. Aju IB's investment criteria include management's capability, ethics and transparency, potential market leadership or ability to control the market, technological barriers to entry, significant market size, profitability and maturity. They also take into consideration portfolio diversification. | Corporate Officer/Principal | 01/10/2017 |
Molecular Templates, Inc. /Old/
 Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Discovers and develops immunotoxins for the treatment of cancer | Directeur/Membre du Conseil | 01/07/2017 |
| G1 THERAPEUTICS, INC. | Directeur/Membre du Conseil | 22/05/2017 |
Citizens Bank, NA (Providence, Rhode Island)
 Citizens Bank, NA (Providence, Rhode Island) Major BanksFinance Provides commercial banking services | Directeur Général | 01/01/2014 |
Cornerstone Pharmaceuticals, Inc.
 Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops anti-cancer drug delivery technology | Corporate Officer/Principal | 01/12/2011 |
Formation de Timothy Sullivan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
27
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Cornerstone Pharmaceuticals, Inc.
Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops anti-cancer drug delivery technology | Commercial Services |
Apellis Pharmaceuticals, Inc.
 Apellis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics and drug delivery technologies to address chronic inflammatory diseases | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aju IB Investment Co., Ltd. (Private Equity)
Aju IB Investment Co., Ltd. (Private Equity) Investment ManagersFinance Aju IB is a long-term investor focused on high technology Korean companies with significant growth potential. Aju IB's investment criteria include management's capability, ethics and transparency, potential market leadership or ability to control the market, technological barriers to entry, significant market size, profitability and maturity. They also take into consideration portfolio diversification. | Finance |
Citizens Bank, NA (Providence, Rhode Island)
Citizens Bank, NA (Providence, Rhode Island) Major BanksFinance Provides commercial banking services | Finance |
Molecular Templates, Inc. /Old/
Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Discovers and develops immunotoxins for the treatment of cancer | Health Technology |
G1 Therapeutics, Inc.
 G1 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment | Health Technology |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
